Abstract Details

Title Remarkable Benefit Persisting Undiminished for 8 Years after Stopping 14 Years of Interferon-[alpha]2A (Inf-[alpha]) Treatment of Fever-Responsive Dysimmune Neuropathy (FRDN): Possibly a Combined Antidysimmune Plus Antiviral Effect, and Thus a Putative Model for Future "Combined Antidysimmune" Therapies

Topic Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 231

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
W. K. Engel, MD, FAAN	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��